BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 3030345)

  • 1. Constitutive activation of oncogenes by chromosomal translocations in B-cell derived tumors.
    Klein G
    AIDS Res; 1986 Dec; 2 Suppl 1():S167-76. PubMed ID: 3030345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conditioned tumorigenicity of activated oncogenes.
    Klein G; Klein E
    Cancer Res; 1986 Jul; 46(7):3211-24. PubMed ID: 3011242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chromosomal translocations in B-cell derived tumors.
    Klein G
    Princess Takamatsu Symp; 1986; 17():159-70. PubMed ID: 3332008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV-B cell interactions: immortalization, rescue from apoptosis, tumorigenicity (a short review).
    Klein G
    Acta Microbiol Immunol Hung; 1996; 43(2-3):97-105. PubMed ID: 8876725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forward and reverse changes in Ig/myc translocation carrying tumors.
    Klein G
    Princess Takamatsu Symp; 1989; 20():135-42. PubMed ID: 2562178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-myc-S mu rearrangement in a murine plasmacytoma without visible chromosomal translocations.
    Ohno S; Migita S; Murakami S
    Oncogene; 1989 Dec; 4(12):1513-7. PubMed ID: 2687771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Location of Myc, Igh, and Igk on Robertsonian fusion chromosomes is inconsequential for Myc translocations and plasmacytoma development in mice, but Rb(6.15)-carrying tumors prefer Igk-Myc inversions over translocations.
    Silva S; Wiener F; Klein G; Janz S
    Genes Chromosomes Cancer; 2005 Apr; 42(4):416-26. PubMed ID: 15645495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological aspects of B-cell derived tumors in humans and rodents.
    Klein G
    Princess Takamatsu Symp; 1988; 19():3-13. PubMed ID: 2855874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiimmunoglobulin inhibition of Burkitt's lymphoma cell proliferation and concurrent reduction of c-myc and mu heavy chain gene expression.
    Arasi VE; Lieberman R; Sandlund J; Kiwanuka J; Novikovs L; Kirsch I; Hollis G; Magrath IT
    Cancer Res; 1989 Jun; 49(12):3235-41. PubMed ID: 2497974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ig/myc translocations of the plasmacytoma-prone BALB/c strain occur independently of the genetic and parental origin of the affected chromosomes 6, 12, and 15.
    Silva S; Babonits M; Klein G
    Genes Chromosomes Cancer; 1996 Nov; 17(3):179-84. PubMed ID: 8946197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new variant 15; 16 translocation in mouse plasmacytoma leads to the juxtaposition of c-myc and immunoglobulin lambda.
    Axelson H; Panda CK; Silva S; Sugiyama H; Wiener F; Klein G; Sumegi J
    Oncogene; 1991 Dec; 6(12):2263-70. PubMed ID: 1766673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene expression and immunoglobulin synthesis in a North American Burkitt (NAB-2) lymphoma cell line with a 8;22 chromosome translocation.
    Popescu NC; Dahlberg JE; Ablashi DV; Monastier M; Bona CA; DiPaolo JA; Hooper WC; Swan DC
    Oncogene Res; 1990; 5(4):295-303. PubMed ID: 1697668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between Burkitt's lymphomas and mouse plasmacytomas in the immunoglobulin heavy chain/c-myc recombinations that occur in their chromosomal translocations.
    Müller JR; Janz S; Potter M
    Cancer Res; 1995 Nov; 55(21):5012-8. PubMed ID: 7585544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translocations among antibody genes in human cancer.
    Leder P
    IARC Sci Publ; 1985; (60):341-57. PubMed ID: 4065947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant class switching juxtaposes c-myc with a middle repetitive element (LINE) and an IgH intron in two spontaneously arising rat immunocytomas.
    Pear WS; Nelson SF; Axelson H; Wahlström G; Bazin H; Klein G; Sümegi J
    Oncogene; 1988 May; 2(5):499-507. PubMed ID: 3131719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular oncogenes and lymphocyte activation.
    Schneider-Schaulies J; Knauer R; Schimpl A; Wecker E
    Behring Inst Mitt; 1987 Jun; (81):110-9. PubMed ID: 3115245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome translocations in B and T cell neoplasias.
    Showe LC; Croce CM
    Semin Hematol; 1986 Oct; 23(4):237-44. PubMed ID: 3535082
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncogenes and chromosomes.
    Crews S
    Biomed Pharmacother; 1983; 37(8):369. PubMed ID: 6667342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.